CanFite

IPO

CanFite is a biotech company in Petah Tikva, Israel, founded in 1994. It has raised $15.0M across 1 round, most recently a $15.0M Corporate Round in July 2025.

Innovative drug development targeting the A3 adenosine receptor

Headquarters
Petah Tikva
Employees
11–50
Founded
1994
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M Corporate RoundJul 2025
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Can-Fite BioPharma is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary drug candidates in Phase II and Phase III clinical development addressing oncology, inflammatory, and metabolic diseases. Can-Fite's platform technology utilizes the Gi protein-associated A3 adenosine receptor (A3AR) as a therapeutic target — highly expressed in inflammatory and cancer cells while showing low expression in normal cells, making it a unique pharmacological target. Founded in 1994 by Pnina Fishman and Ilan Cohn, Can-Fite is headquartered in Petah Tikva, Israel and is listed on both the Tel Aviv Stock Exchange (TASE:CFBI) and NYSE American (CANF).

Summary

It lists 11–50 employees. It has raised $15.0M in total across 1 round, most recently a $15.0M Corporate Round in Jul 2025. Investors include Giza Venture Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundJul 2025
$15.0M

Sign up to see all 3 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CanFite on Indexed.vc
<a href="https://indexed.vc/companies/canfite"><img src="https://indexed.vc/api/badge/company/canfite" alt="CanFite on Indexed.vc" width="260" height="76" /></a>